CESPEDES NAVARRO, M. VIRTUDES IR
mcespedes@santpau.cat
Caruana Santiago, Pablo IR
Edwards, Maria Charlotte IR
Farres Rubi, Alba FGS
Luna Guibourg, Rocio FGS
Magret Descamps, Eva FGS
Martin Lorente, Cristina FGS
Muñoz Sanchez, Raquel FGS
Rovira Negre, Ramon FGS
Soler Moreno, Cristina FGS
Teixeira, Natalia FGS
Zapater Enrique, Oscar FGS
(JIF 2023)
-Cueva JF, Palacio I, Churruca C, Herrero A, Pardo B, Constenla M, Santaballa A, Manso L, Estévez P, Maximiano C, Legerén M, Marquina G, de Juan A, Quindós M, Sánchez L, Barquin A, Fernández I, Martín C, Juárez A, Martín T, García Y, Yubero A, Gallego A, Martínez Bueno A, Guerra E, González-Martín A. Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme. Eur J Cancer. 2023; Mar;182:3-14. DOI: 10.1016/j.ejca.2022.12.023. PMID:36706655. IF:7,600 (Q1/2D). Document type: Article.
-Espanol P, RAMON N, Caruana P, Luna R, Soler C, Teixeira N, Rodriguez F, Gallardo A, Edwards M, Porta O, Gamez M, Sanchez O, Llurba E, Corchero JL, Cespedes MV. Dopamine receptors D1 and D2 show prognostic significance and potential therapeutic applications for endometrial cancer patients. GYNECOLOGIC ONCOLOGY. 2023; 176. DOI:10.1016/j.ygyno.2023.06.019. PMID:37437489. IF:4,500 (Q1/1D). Document type: Article.
-Espanol P, Luzarraga A, Teixeira N, Soler C, Luna R, RAMON N. An institutional study: Does Body Mass Index influence surgical approach, surgical morbidities, and outcomes in endometrial cancer patients?. Facts Views And Vision In Obgyn. 2023; 15(3). DOI:10.52054/FVVO.15.3.081. PMID:37742203. IF:1,700 (Q3/6D). Document type: Article.
-Garcia NG, Moreno CS, Teixeira N, Lloret PE, Guibourg R, RAMON N. Comparison of laparoscopy and laparotomy in the management of early-stage ovarian cancer. Gynecology And Minimally Invasive Therapy. 2023; 12(2). DOI:10.4103/gmit.gmit_99_22. PMID:37416098. IF:1,400 (Q3/7D). Document type: Article.
-Habib N, Moufawad G, Hayek J, Futcher F, Chiantera V, RAMON N, Devassy R, Centini G, Mereu L. A Reappraisal of Lymphadenectomy in Common Gynecological Cancers. Clinical and Experimental Obstetrics & Gynecology. 2023; 50(9):181. DOI:10.31083/j.ceog5009181. IF:0,400 (Q4/9D). Document type: Review
-Hernansanz A, RAMON N, Basomba J, Comas R, Casals A. EndoTrainer: a novel hybrid training platform for endoscopic surgery. International Journal of Computer Assisted Radiology and Surgery. 2023; 18(5). DOI:10.1007/s11548-023-02837-x. PMID:36781742. IF:2,300 (Q2/3D). Document type: Article.
-Labidi SI, Rodrigues M, Sandoval JL, Kurtz JE, Heitz F, Mosconi AM, Romero I, Denison U, Nagao S, Vergote I, Parma G, Nøttrup TJ, Rouleau E, Garnier G, El A, Zamagni C, Martín C, Pujade E, Fiévet A, Ray IL. Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer: phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis. ANNALS OF ONCOLOGY. 2023; 34(2). DOI:10.1016/j.annonc.2022.11.003. PMID:36564284. IF:56,700 (Q1/1D). Document type: Article
-Pujade E, Brown J, Barnicle A, Wessen J, Lao P, Criscione SW, du A, Lorusso D, Romero I, Petru E, Yoshida H, Vergote I, Colombo N, Hietanen S, Provansal M, Schmalfeldt B, Pignata S, Martín C, Berton D, Runnebaum IB, Ray I. Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial. JCO Precision Oncology. 2023; 7:e2200258. DOI:10.1200/PO.22.00258. PMID:36716415. IF:5,300 (Q1/2D). Document type: Article.
-Revilla G, Al Qtaish N, Caruana P, Sainz M, Lopez T, Rodriguez F, Paez V, Li CD, Vallverdú NF, Edwards M, Moral A, Pérez JI, Escolà JC, Pedraz JL, Gallego I, Corcoy R, Céspedes MV, Puras G, Mato E. Lenvatinib-Loaded Poly(lactic-co-glycolic acid) Nanoparticles with Epidermal Growth Factor Receptor Antibody Conjugation as a Preclinical Approach to Therapeutically Improve Thyroid Cancer with Aggressive Behavior. Biomolecules. 2023; 13(11):1647. DOI:10.3390/biom13111647. PMID:38002329. IF:4,800 (Q1/3D). Document type: Article.
-Rodriguez A, Maroto P, Font A, Martin C, Mellado B, Corbera A, Orrillo M, Reig O, Querol R, Rios A, Cano L, Alonso J, Martinez G, Galtes S, Taus A, Martinez M, Juanpere N, Juan O, Bellmunt J. Safety and efficacy of avelumab plus carboplatin in patients with metastatic castration-resistant prostate cancer in an open-label Phase Ib study. BRITISH JOURNAL OF CANCER. 2023; 128(1). DOI:10.1038/s41416-022-01991-4. PMID:36289372. IF:6,400 (Q1/2D). Document type: Article.
-Tarrie JE, Capo JP, Sanchez RM. Update on the possibilities of hormonal medical treatment for heavy menstrual bleeding. CLINICA E INVESTIGACION EN GINECOLOGIA Y OBSTETRICIA. 2023; 50(1). DOI: 10.1016/j.gine.2022.100819. IF:0,100 (Q4/10D). Document type: Review.
(JIF 2022)